Pieter Sonneveld
- Hematology top 0.01%
- Oncology top 0.05%
- Molecular Biology top 0.1%
- Genetics top 0.05%
- Pathology and Forensic Medicine top 0.1%
- Co-authors
- Jesús F. San MiguelBob LöwenbergKees NooterBronno van der HoltMaría‐Victoria MateosJoan BladéHartmut GoldschmidtMario Boccadoro
- Topics
- Multiple Myeloma Research and Treatments (434 papers)Protein Degradation and Inhibitors (189 papers)Cancer Treatment and Pharmacology (114 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Pieter Sonneveld
617 papers receiving 27.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Hematology 17.8k
- Oncology 14.2k
- Molecular Biology 13.9k
- Genetics 4.0k
- Pathology and Forensic Medicine 3.8k
Countries citing papers authored by Pieter Sonneveld
This map shows the geographic impact of Pieter Sonneveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Sonneveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Sonneveld more than expected).
Fields of papers citing papers by Pieter Sonneveld
This network shows the impact of papers produced by Pieter Sonneveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Sonneveld. The network helps show where Pieter Sonneveld may publish in the future.
Co-authorship network of co-authors of Pieter Sonneveld
This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Sonneveld. A scholar is included among the top collaborators of Pieter Sonneveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Sonneveld. Pieter Sonneveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 16 | |
| 6 | 27 | |
| 7 | 7 | |
| 8 | HOVON 104; FINAL RESULTS FROM A MULTICENTER, PROSPECTIVE PHASE II STUDY OF BORTEZOMIB BASED INDUCTION TREATMENT FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH DE NOVO AL AMYLOIDOSIS | 1 |
| 9 | 275 | |
| 10 | 12 | |
| 11 | 30 | |
| 12 | 150 | |
| 13 | 142 | |
| 14 | 179 | |
| 15 | 61 | |
| 16 | 121 | |
| 17 | Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma. | 23 |
| 18 | Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. | 75 |
| 19 | 1 | |
| 20 | 1 |
About Pieter Sonneveld
Pieter Sonneveld is a scholar working on Hematology, Oncology and Genetics, having authored 653 papers that have together received 27.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (434 papers), Protein Degradation and Inhibitors (189 papers) and Cancer Treatment and Pharmacology (114 papers). The work is most often cited by research in Hematology (17.8k citations), Oncology (14.2k citations) and Genetics (4.0k citations). Pieter Sonneveld has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Jesús F. San Miguel, Bob Löwenberg, Kees Nooter, Bronno van der Holt, María‐Victoria Mateos, Joan Bladé, Hartmut Goldschmidt, Mario Boccadoro, Sonja Zweegman and Antonio Palumbo. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.